REVIEW
Nobel Med 2015; 11(1): 14-21

RISK EVALUATION, RISK COMMUNICATION AND PERINATAL EVALUATION IN PREGNANCIES WITH DRUG EXPOSURE

Yusuf Cem Kaplan, Sefa Kelekçi, Ömer Demir
ABSTRACT
Drug use pregnancy is common. The possibility that the drug exposure may lead to untoward effects on fetus poses a serious problem for pregnant patient and her physician. Lack of information regarding the risks of drug exposure may lead to an erroneously high risk perception which may lead to an elective termination of a desired pregnancy. On the other hand, physicians may be sued for not providing the patient with adequate information regarding the risks of drug exposure, in case the patient gives birth to a child with a drug specific congenital anomaly. Most effective solution of this problem is combining a Teratology Information Service, which includes the evaluation of risks of the exposed drug and risk communication, with perinatal evaluation. This article aims to describe how the evidence based risk evaluation, risk communication and perinatal evaluation procedures are implemented in pregnancies with drug exposure.
Keywords
Pregnancy Drugs Drug use Congenital anomaly Birth defect Teratogen Perinatal evaluation Risk evaluation Risk communication

Article Details

Download Full Text in PDF Format Read Full Text Other Articles in This Issue

THE PERSPECTIVE OF INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY, AND HEALTH (ICF) IN OBESITY

05-13

Sina Esmaeilzadeh, Merih Akpınar, Aydan Oral

REVIEW Nobel Med 2015; 11(1): 05-13

RISK EVALUATION, RISK COMMUNICATION AND PERINATAL EVALUATION IN PREGNANCIES WITH DRUG EXPOSURE

14-21

Yusuf Cem Kaplan, Sefa Kelekçi, Ömer Demir

REVIEW Nobel Med 2015; 11(1): 14-21

INVESTIGATION OF GENOTOXICITY IN INTESTINAL EPITHELIAL CELLS AND LYMPHOCYTES OF CELIAC PATIENTS

22-26

Özlem Yüce, Ayhan Gazi Kalaycı, Ali Okuyucu, Gönül Caltepe, Abdulkerim Bedir

RESEARCH ARTICLE Nobel Med 2015; 11(1): 22-26

RELATIONSHIP OF DOMESTIC PHYSICAL VIOLENCE AND SEVERITY OF PAIN, DEPRESSION AND ANXIETY LEVELS IN FIBROMYALGIA CASES

27-32

Ürün Özer, Esra Selimoğlu, Engin Badur, Ersin Uygun, Çağatay Karşıdağ

RESEARCH ARTICLE Nobel Med 2015; 11(1): 27-32

HIP PAIN IN PREGNANCY

33-36

Metin Uzun , Ercan Baştu, Burak Beksaç, Adnan Kara, Müjdat Adaş

RESEARCH ARTICLE Nobel Med 2015; 11(1): 33-36

EVALUATION OF SECONDARY AND TERTIARY HEALTH CENTERS EMERGENCY SERVICE APPLICATIONS DUE TO SUICIDAL ATTEMPTS

37-42

Binali Çatak, Can Öner, Sevgi Baştürk, Oya Karaali, İrfan Oğuz, Resul Özbek

RESEARCH ARTICLE Nobel Med 2015; 11(1): 37-42

EFFECT OF INTRAOPERATIVE MEAN BLOOD PRESSURE ON POSTOPERATIVE COGNITIVE FUNCTION IN GERIATRIC PATIENTS WITH HYPERTENSION

43-48

Pınar Özlülerden, Seher İlhan, İbrahim Öztürk, Hakan Erbay

RESEARCH ARTICLE Nobel Med 2015; 11(1): 43-48

INFLUENCE OF SEASONALITY ON SUICIDAL HANGING IN ISTANBUL, 1979-2012: ASSOCIATIONS WITH GENDER, AGE, LOCATION AND INSTRUMENTS OF SUICIDE

49-54

Bahadır Kumral, Şafak Taktak, Ayla Ünsal, Taşkın Özdeş, Yalçın Büyük, Rıfat O. Özdemirel

RESEARCH ARTICLE Nobel Med 2015; 11(1): 49-54

SCALE DEVELOPMENT STUDY ON ETHICAL PROBLEMS: AN APPLICATION ON MEDICAL STUDENTS

55-63

Engin Kurt, Ahmet Keser, Yunus Gökmen

RESEARCH ARTICLE Nobel Med 2015; 11(1): 55-63

FREQUENCY AND THE FACTORS AFFECTING VIOLENCE TOWARDS PREGNANT WOMAN ADMITTED TO A UNIVERSITY HOSPITAL PREGNANCY OUTPATIENT CLINIC

64-70

Filiz Bolu, Atilla Senih Mayda, Muammer Yılmaz

RESEARCH ARTICLE Nobel Med 2015; 11(1): 64-70

COMPARISON OF PULSE OXYMETER AND CEREBRAL OXYMETER VALUES IN HEALTHY NEWBORNS IN THE FIRST FIVE MINUTES OF LIFE

71-75

Gökmen A. Taşkın, Avni Kaya, Ertan Sal, Lokman Üstyol, Erdal Peker, Oğuz Tuncer, Ercan Kırımi

RESEARCH ARTICLE Nobel Med 2015; 11(1): 71-75

COMPARISON OF EFFICACY AND SAFETY OF LOTEPREDNOL ETABONATE 0.5% VERSUS FLUOROMETHOLONE ACETAT 0.1% FOR THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS IN PEDIATRIC SUBJECTS

76-82

Mustafa Eliaçık, Fırat Erdoğan, Hüseyin Bayramlar, Sevil Karaman, Gökhan Gülkılık

RESEARCH ARTICLE Nobel Med 2015; 11(1): 76-82

SERUM TOTAL OXIDATIVE AND ANTIOXIDATIVE STATUS IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS

83-86

Ercan Madenci, Şükrü Güçbey, İrfan Koca, Erhan İbas, Hülya Çiçek

RESEARCH ARTICLE Nobel Med 2015; 11(1): 83-86

THE IMPORTANCE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE BRUCELLOSIS

87-91

Nazlım Aktuğ Demir, Hatice Türk Dağı, Duygu Fındık, Şua Sümer, Onur Ural, Servet Kölgelier

RESEARCH ARTICLE Nobel Med 2015; 11(1): 87-91

BREAST MALIGNANCY WITH LESER-TRELAT SIGN IN A GERIATRIC PATIENT

92-93

Pınar Yıldız, Hayrettin Dizen, Mustafa Yıldız, Ahmet Volkan Yıldırım

REPORT Nobel Med 2015; 11(1): 92-93

PITUITARY ADRENAL INSUFFICIENCY IN A CANCER PATIENT UNDER OPIOID TREATMENT

94-96

Fatma Avcı Merdin, Alparslan Merdin, Melek Karakurt Eryılmaz, Safiye Arık, Şeyda Gündüz, Hasan Şenol Coşkun, Hasan Altunbaş

REPORT Nobel Med 2015; 11(1): 94-96

CHOROIDAL NEOVASCULAR MEMBRANE ASSOCIATED WITH SILDENAFIL

97-99

Harun Çakmak, Sema Oruç Dündar, Tolga Kocatürk

REPORT Nobel Med 2015; 11(1): 97-99

SAFİYE ALİ

100-102

Doç. Dr. İnci Hot

A PORTRAIT Nobel Med 2015; 11(1): 100-102

RISK EVALUATION, RISK COMMUNICATION AND PERINATAL EVALUATION IN PREGNANCIES WITH DRUG EXPOSURE

14-21

Yusuf Cem Kaplan, Sefa Kelekçi, Ömer Demir

REVIEW Nobel Med 2015; 11(1): 14-21

HIP PAIN IN PREGNANCY

33-36

Metin Uzun , Ercan Baştu, Burak Beksaç, Adnan Kara, Müjdat Adaş

RESEARCH ARTICLE Nobel Med 2015; 11(1): 33-36

FREQUENCY AND THE FACTORS AFFECTING VIOLENCE TOWARDS PREGNANT WOMAN ADMITTED TO A UNIVERSITY HOSPITAL PREGNANCY OUTPATIENT CLINIC

64-70

Filiz Bolu, Atilla Senih Mayda, Muammer Yılmaz

RESEARCH ARTICLE Nobel Med 2015; 11(1): 64-70
  • Pubmed Style
    Yusuf Cem Kaplan, Sefa Kelekçi, Ömer Demir. [GEBELİKTE İLAÇ MARUZİYETİ SONRASINDA RİSK DEĞERLENDİRMESİ, RİSK İLETİŞİMİ VE PERİNATAL DEĞERLENDİRME]. Nobel Med 2015; 11(1): 14-21, Turkish.
  • Web Style
    Yusuf Cem Kaplan, Sefa Kelekçi, Ömer Demir. [GEBELİKTE İLAÇ MARUZİYETİ SONRASINDA RİSK DEĞERLENDİRMESİ, RİSK İLETİŞİMİ VE PERİNATAL DEĞERLENDİRME]. www.nobelmedicus.com/en/Article.aspx?m=1716 [Access: Mayıs 24, 2021], Turkish.
  • AMA (American Medical Association) Style
    Yusuf Cem Kaplan, Sefa Kelekçi, Ömer Demir. [GEBELİKTE İLAÇ MARUZİYETİ SONRASINDA RİSK DEĞERLENDİRMESİ, RİSK İLETİŞİMİ VE PERİNATAL DEĞERLENDİRME]. Nobel Med 2015; 11(1): 14-21, Turkish.
  • Vancouver/ICMJE Style
    Yusuf Cem Kaplan, Sefa Kelekçi, Ömer Demir. [GEBELİKTE İLAÇ MARUZİYETİ SONRASINDA RİSK DEĞERLENDİRMESİ, RİSK İLETİŞİMİ VE PERİNATAL DEĞERLENDİRME]. Nobel Med (2015); 11(1): 14-21, [cited Mayıs 24, 2021], Turkish.
  • Harvard Style
    Yusuf Cem Kaplan, Sefa Kelekçi, Ömer Demir. (2015) [GEBELİKTE İLAÇ MARUZİYETİ SONRASINDA RİSK DEĞERLENDİRMESİ, RİSK İLETİŞİMİ VE PERİNATAL DEĞERLENDİRME]. Nobel Med, 11(1): 14-21, Turkish.